logo-loader

First push into biomed 'very good for Versarien' says CEO

Published: 14:44 28 Oct 2016 BST

Versarien Plc (LON:VRS) subsidiary 2-DTech is involved in a new project to develop a new generation of medical technologies, using graphene.

Chief executive Neil Ricketts tells Proactive: ''We've been put forward as a material supplier for this project. It's very good for us because it's not going to be too time consuming for our team and it gets our material out into a much wider audience''.

The project is funded by the UK government’s Engineering and Physical Sciences Research Council (EPSRC), and it aims to explore how graphene can improve treatment of diseases including cancer, diabetes and dementia.

Versarien advances in global graphene market with strategic asset sale and...

Versarien PLC (AIM:VRS, OTC:VRSRF) CEO Stephen Hodge speaks to Proactive's Stephen Gunnion about the significant steps the company has taken to refine its business strategy and focus on its core technologies and intellectual properties (IP). In a notable move, the company has sold its Korean...

1 week, 6 days ago